Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,604 | -43,099 | -58,900 | -35,374 | -30,310 |
| Depreciation Amortization | 183 | 2,033 | 3,395 | 2,472 | 823 |
| Income taxes - deferred | N/A | -513 | 6 | 8 | 8 |
| Accounts receivable | 10,042 | -7,826 | -1,569 | 1,131 | -1,638 |
| Accounts payable and accrued liabilities | 261 | -2,441 | 1,765 | 2,944 | 660 |
| Other Working Capital | -7,978 | 189,965 | 43,260 | -248 | 60,673 |
| Other Operating Activity | 6,575 | 32,254 | 10,011 | 1,652 | 1,586 |
| Operating Cash Flow | $-75,521 | $170,373 | $-2,032 | $-27,415 | $31,802 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,714 | -119,707 | 47,983 | -128,151 | N/A |
| PPE Investments | -3,788 | -1,559 | -2,124 | -1,594 | -1,663 |
| Other Investing Activity | 0 | 0 | 0 | -817 | 0 |
| Investing Cash Flow | $5,926 | $-121,266 | $45,859 | $-130,562 | $-1,663 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -3,067 | -1,256 |
| Common Stock Issued | 139,624 | 23,796 | 930 | 82,040 | 8 |
| Other Financing Activity | 0 | 0 | 66 | 74,430 | 26,802 |
| Financing Cash Flow | $139,624 | $23,796 | $996 | $153,403 | $25,554 |
| Beginning Cash Position | 178,465 | 105,562 | 60,739 | 64,396 | 8,703 |
| End Cash Position | 248,494 | 178,465 | 105,562 | 59,822 | 64,396 |
| Net Cash Flow | $70,029 | $72,903 | $44,823 | $-4,574 | $55,693 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,521 | 170,373 | -2,032 | -27,415 | 31,802 |
| Capital Expenditure | -3,788 | -1,559 | -2,176 | -1,594 | -1,663 |
| Free Cash Flow | -79,309 | 168,814 | -4,208 | -29,009 | 30,139 |